Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

NORGESTIMATE AND ETHINYL ESTRADIOL Drug Profile

« Back to Dashboard

What is the patent landscape for Norgestimate And Ethinyl Estradiol, and when can generic versions of Norgestimate And Ethinyl Estradiol launch?

Norgestimate And Ethinyl Estradiol is a drug marketed by Watson Labs, Lupin Ltd, Mylan Labs Ltd, Glenmark Generics, Lupin Pharms, Glenmark Pharms, Amneal Pharms, Haupt Pharma, and Oc Pharma. and is included in seventeen NDAs.

The generic ingredient in NORGESTIMATE AND ETHINYL ESTRADIOL is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.

Summary for Tradename: NORGESTIMATE AND ETHINYL ESTRADIOL

Patents:0
Applicants:9
NDAs:17
Suppliers / Packagers: see list8
Bulk Api Vendors: see list1
Clinical Trials: see list39,561
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NORGESTIMATE AND ETHINYL ESTRADIOL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
NORGESTIMATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norgestimate
TABLET;ORAL-28076626-001Aug 17, 2006DISCNNoNo► Subscribe► Subscribe
Glenmark Pharms
NORGESTIMATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norgestimate
TABLET;ORAL-28204057-001Feb 23, 2016ABRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
NORGESTIMATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norgestimate
TABLET;ORAL-28202132-001Sep 9, 2015ABRXNoNo► Subscribe► Subscribe
Oc Pharma
NORGESTIMATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norgestimate
TABLET;ORAL-28200383-001Apr 7, 2015ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
NORGESTIMATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norgestimate
TABLET;ORAL-28203865-001Oct 27, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot